GCÐMS Determination of Flunitrazepam and its Major Metabolite in Whole Blood and Plasma

Published: Journal of Analytical Toxicology, Volume 23, Number 6, October 1999, pp.486-489

GC–MS Determination of Flunitrazepam and its Major Metabolite in Whole Blood and Plasma
M.A. ElSohly, S. Feng, S.J. Salamone, and R. Brenneisen

A gas chromatography–mass spectrometry method was developed for the analysis of flunitrazepam (FN) and its major metabolite, 7-amino-flunitrazepam (7-amino-FN), in both plasma and whole blood. The method was based on acid hydrolysis of the samples after dilution with HPLC water followed by extraction and derivatization (heptafluorobutyrate) of the resulting benzophenones. Analysis of plasma and whole blood samples from subjects administered 2-mg doses of FN showed that FN was only detected in whole blood (LOD 5 ng/mL) and not in plasma. However, 7-amino-FN was detected in both plasma and whole blood, although the levels were much higher in plasma. 7-Amino-FN was detected for the entire period of specimen collection (12 h), but FN was only detected in whole blood for 4 h after ingestion with peak levels after 1 h.

Reproduction of editorial content of this journal is prohibited without publisher’s permission.

This article is available in its entirety by fax for $40.00 each.
Visa, MasterCard and AMEX accepted.

To order electronically click here
or call: 847-647-2900 ext. 1323
or fax request to: 847-647-1155.

Please indicate JAT volume and issue along with page numbers.